Inactive Instrument

Highlights VAXGEN OTC Bulletin Board

Equities

VXGN

US9223902084

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

2021	Diadexus, Inc. Went Out of Business	CI
2018	Motion for Asset Sale Approved for Diadexus, Inc.	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Diazyme Laboratories, Inc. completed the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	31/07/16	CI
General Atomics Corp. entered into purchase agreement to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $4.8 million.	28/07/16	CI
Cleveland HeartLab, Inc. cancelled the acquisition of operational assets from Diadexus, Inc. (OTCPK:DDXS.Q).	19/07/16	CI
Cleveland HeartLab, Inc. agreed to acquire operational assets from Diadexus, Inc. (OTCPK:DDXS.Q) for $7 million.	06/07/16	CI
Diadexus, Sonic Healthcare USA Sign National Agreement for PLAC Activity Test	23/05/16	CI
Diadexus, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2016	29/04/16	CI
Diadexus, Inc. Provides Revenue Guidance for the First Quarter of 2016	19/04/16	CI
Diadexus, Inc. Announces Unaudited Financial Results for the Fourth Quarter and Full Year Ended December 31, 2015	29/03/16	CI
Diadexus, Inc. Presents New Plac(r) Activity Data from the Regards Study at 2015 American Heart Association Scientific Sessions	11/11/15	CI
Diadexus, Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2015	26/10/15	CI
DiaDexus Signs License Agreement with OriGene Technologies and Wuxi OriGene Biotechnology	08/09/15	CI
Diadexus, Inc. Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended June 30, 2015; Rescinds Revenue Guidance for 2015	13/08/15	CI
Diadexus And Mayo Clinic Join Forces On PLAC Activity Test to Improve Patient Care For Cardiovascular Diseases	28/07/15	CI
DiaDexus, Inc. Reports Unaudited Earnings Results for the First Quarter Ended March 31, 2015	12/05/15	CI
Diadexus, Inc. Announces Results from the Plac Test for Lp-PLA2 Activity (PLAC Activity Test) clinical validation study	24/03/15	CI
DiaDexus, Inc. Announces Unaudited Financial Results for the Fourth Quarter and Full Year Ended December 31, 2014	11/03/15	CI
DiaDexus, Inc. Reiterates Revenue Guidance for the Year 2014	05/01/15	CI
DiaDexus Inc. Receives FDA Clearance for PLAC Activity Test to Assess Coronary Heart Disease Risk	15/12/14	CI
DiaDexus, Inc. Announces Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014 Provides Revenue Guidance for the Full Year of 2014	05/11/14	CI
DiaDexus, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014	28/07/14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights VAXGEN OTC Bulletin Board

Equities

VXGN

US9223902084

Highlights

Filters